Graftac 1 Prolonged Release


Capsules
scheduling status
S4
registration number
55/34/0855
What Graftac 1 Prolonged Release contains
Each capsule contains 1,000 mg of tacrolimus equivalent to 1,022 mg of tacrolimus monohydrate.
other ingredients
Capsule content: Ethylcellulose, hypromellose type 2910, lactose monohydrate, magnesium stearate Body Composition: Sunset yellow FCF (E110), allura red AC (E129), brilliant blue FCF (E133), titanium dioxide (E171), gelatine Cap Composition: Titanium dioxide (E171), Gelatine Imprinting ink: Shellac Glaze in ethanol, N-butyl alcohol, allura Red AC aluminium lake (E129), brilliant blue FCF aluminium lake (E133), isopropyl alcohol, sunset yellow FCF aluminium lake (E110), propylene glycol (E1520), lecithin (soya), simeticone.
Therapeutic classification
A.34 Other (Immuno-suppressive macrolide lactone).
© 2026 SAHPRA. ALL RIGHTS RESERVED